SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.

Autor: Lee EJ; Division of Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY., Beltrami-Moreira M; Division of Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY., Al-Samkari H; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Cuker A; Department of Medicine and.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., DiRaimo J; Platelet Disorder Support Association, Cleveland, OH., Gernsheimer T; Division of Hematology, University of Washington, Seattle, WA., Kruse A; Platelet Disorder Support Association, Cleveland, OH., Kessler C; Division of Hematology/Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC., Kruse C; Platelet Disorder Support Association, Cleveland, OH., Leavitt AD; Division of Hematology/Oncology, University of California-San Francisco, San Francisco, CA., Lee AI; Division of Hematology, Yale School of Medicine, New Haven, CT., Liebman HA; Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California, Los Angeles, CA., Newland AC; Department of Haematology, Centre for Haematology, Barts and the London School of Medicine and Dentistry, London, United Kingdom., Ray AE; Division of Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY., Tarantino MD; The Bleeding and Clotting Disorders Institute, Peoria, IL.; Department of Medicine, University of Illinois College of Medicine-Peoria, Peoria, IL., Thachil J; Department of Haematology, Manchester University Hospitals, Manchester, United Kingdom; and., Kuter DJ; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Cines DB; Department of Medicine and.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Bussel JB; Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY.

Publikováno v: Blood [Blood] 2022 Mar 10; Vol. 139 (10), pp. 1564-1574.

Protease-activated receptor 2 deficient mice develop less angiotensin II induced left ventricular hypertrophy but more cardiac fibrosis.

Autor: Meyer zu Schwabedissen, Albrecht¹ (AUTHOR), Vergarajauregui, Silvia² (AUTHOR), Bertog, Marko³ (AUTHOR), Amann, Kerstin¹ (AUTHOR), Engel, Felix B.² (AUTHOR), Daniel, Christoph¹ (AUTHOR) Christoph.Daniel@uk-erlangen.de

Publikováno v: PLoS ONE. 12/5/2024, Vol. 19 Issue 12, p1-22. 22p.

THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: OUR EXPERIENCE.

Autor: Golubović, Ivana^1,2 drivanagolubovic@gmail.com, Vučić, Miodrag^1,3, Ćojbašić, Irena^1,3, Tijanić, Ivan^1,3, Nikolić, Vesna¹, Mladenović, Andrijana^1,2, Jovanović, Nemanja^2,4

Publikováno v: Acta Medica Medianae. Oct2024, Vol. 63 Issue 3, p133-139. 7p.

Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.

Autor: Pavord S; Department of Haematology, Oxford University Hospitals, Oxford, UK., Thachil J; Department of Haematology, Manchester University Foundation Trust, Manchester, UK., Hunt BJ; Department of Haematology, Guy's and St Thomas' Hospital, London, UK., Murphy M; Department of Haematology, John Radcliffe Hospital, NHSBT, Oxford, UK., Lowe G; Department of Haematology, University Hospitals of Birmingham, Birmingham, UK., Laffan M; Department of Haematology, Hammersmith Hospital, Du Cane Road, UK., Makris M; Department of Haematology, Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK., Newland AC; Department of Haematology, Barts and the London School of Medicine and Dentistry, London, UK., Provan D; Department of Haematology, Queen Mary University of London, Bart's and The London School of Medicine and Dentistry, Institute of Cell and Molecular Science, London, UK., Grainger JD; Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Hill QA; Department of Haematology, St James's University Hospital, Leeds, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (6), pp. 1038-1043. Date of Electronic Publication: 2020 Jun 02.

Predictors for spontaneous remission in childhood chronic immune thrombocytopenia.

Autor: Yang YN; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan., Yeh YH; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan., Chen JS; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan.; Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan., Chen LW; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan.; Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan., Lin YC; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan.; Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan., Cheng CN; Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 138, Shengli Road, Tainan, 704302, Taiwan. can66@mail.ncku.edu.tw.; Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan. can66@mail.ncku.edu.tw.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Oct 27. Date of Electronic Publication: 2024 Oct 27.